Literature DB >> 22566587

Parathyroid imaging: the importance of dual-radiopharmaceutical simultaneous acquisition with 99mTc-sestamibi and 123I.

Scott A Caveny1, William C Klingensmith, Wesley E Martin, Adrienne Sage-El, Robert C McIntyre, Christopher Raeburn, Pamela Wolfe.   

Abstract

UNLABELLED: Our objective was to compare the accuracy of 3 imaging protocols for the detection of parathyroid adenomas: single-tracer, dual-phase imaging with (99m)Tc-sestamibi; dual-tracer, single-phase imaging with simultaneous acquisition of (99m)Tc-sestamibi and (123)I images; and dual-tracer, dual-phase imaging with simultaneous acquisition of (99m)Tc-sestamibi and (123)I images. MATERIALS: Thirty-seven patients with surgical proof of parathyroid adenomas were evaluated. Three different protocols were derived from a single study in each patient, resulting in an intrapatient intrastudy comparison. The first derived protocol was the conventional dual-phase protocol with (99m)Tc-sestamibi consisting of anterior and anterior-oblique pinhole images of the neck at 15 min and 3 h plus parallel-hole images of the neck and upper chest at both imaging times. The second derived protocol was a dual-tracer, single-phase protocol consisting of administration of (123)I followed 2 h later by (99m)Tc-sestamibi. Fifteen minutes later, anterior and anterior oblique pinhole images of the (99m)Tc-sestamibi and (123)I were acquired simultaneously, allowing generation of perfectly coregistered subtraction images. Parallel-hole images of the neck and upper chest were also obtained. The third protocol was the same as the second except that the same imaging protocol was repeated at 3 h. Two experienced nuclear medicine physicians indicated the location of any identified lesion and graded the certainty of diagnosis on a 3-point scale.
RESULTS: Thirty-seven patients had 41 parathyroid adenomas. For the 2 observers combined, the localization success rate was 66% for the single-tracer, dual-phase protocol; 94% for the dual-tracer, single-phase protocol; and 90% for the dual-phase, dual-tracer protocol. Both dual-tracer protocols were significantly more accurate than the single-tracer protocol (P < 0.01); there was no significant difference between the 2 dual-tracer protocols. In addition, the degree of certainty of localization was greater with the 2 dual-tracer protocols than the single-tracer protocol (P < 0.001).
CONCLUSION: A dual-tracer, single-phase parathyroid imaging protocol consisting of simultaneous acquisition of (99m)Tc-sestamibi and (123)I images with pinhole collimation at 15 min and perfectly coregistered subtraction results in a higher degree of accuracy and a greater degree of diagnostic certainty than the commonly used single-tracer, dual-phase protocol of imaging (99m)Tc-sestamibi alone at 15 min and 3 h. The addition of delayed imaging to the dual-tracer protocol did not improve results.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22566587     DOI: 10.2967/jnmt.111.098400

Source DB:  PubMed          Journal:  J Nucl Med Technol        ISSN: 0091-4916


  6 in total

1.  Incremental value of CT in the localization of parathyroid adenomas.

Authors:  Feng Xu; Behram Pastakia; Frank Liu
Journal:  Radiol Case Rep       Date:  2015-12-03

2.  18F-Fluorocholine PET/CT as a second line nuclear imaging technique before surgery for primary hyperparathyroidism.

Authors:  Alessio Imperiale; David Taïeb; Elif Hindié
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-04       Impact factor: 9.236

3.  Comparison of hyperparathyroidism types and utility of dual radiopharmaceutical acquisition with Tc99m sestamibi and 123I for localization of rapid washout parathyroid adenomas.

Authors:  Y S Kushchayeva; S H Tella; S V Kushchayev; D Van Nostrand; K Kulkarni
Journal:  Osteoporos Int       Date:  2019-01-31       Impact factor: 4.507

Review 4.  Parathyroid scintigraphy in renal hyperparathyroidism: the added diagnostic value of SPECT and SPECT/CT.

Authors:  David Taïeb; Pablo Ureña-Torres; Paolo Zanotti-Fregonara; Domenico Rubello; Alice Ferretti; Ioline Henter; Jean-François Henry; Francesca Schiavi; Giuseppe Opocher; Johan G Blickman; Patrick M Colletti; Elif Hindié
Journal:  Clin Nucl Med       Date:  2013-08       Impact factor: 7.794

5.  (99m)Technetium Sestamibi-(123)Iodine Scintigraphy Is More Accurate Than (99m)Technetium Sestamibi Alone before Surgery for Primary Hyperparathyroidism.

Authors:  Eeva M Ryhänen; Jukka Schildt; Ilkka Heiskanen; Mika Väisänen; Aapo Ahonen; Eliisa Löyttyniemi; Camilla Schalin-Jäntti; Matti J Välimäki
Journal:  Int J Mol Imaging       Date:  2015-02-01

6.  99mTc-Sestamibi/123I Subtraction SPECT/CT in Parathyroid Scintigraphy: Is Additional Pinhole Imaging Useful?

Authors:  Virpi Tunninen; Pekka Varjo; Tomi Kauppinen; Anu Holm; Hannu Eskola; Marko Seppänen
Journal:  Int J Mol Imaging       Date:  2017-10-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.